Hormone therapy became a popular method to help SBS patients accelerate intestinal adaptation with successful application of growth hormone and GLP-2 [18]. The gene discussed is GCG; the disease is macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.